Lily Cheung serves as Executive at PLIANT THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Lily Cheung has executed 3 insider transactions totaling $9.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 22, 2026 involved receiving (via award) 300,000 shares valued at $0.
Lily Cheung currently holds 300,000 shares of PLIANT THERAPEUTICS, INC. (PLRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lily Cheung has been a net seller of PLRX stock. They have purchased $0 and sold $9.6K worth of shares.
Lily Cheung's most recent insider trade was on Jan 22, 2026, when they sold 300,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.28 |
| Discretionary |
| Jan 23, 2024 | PLRX | $0 | Award | 26,000 | $N/A | Discretionary |